Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone

This study has been terminated.
(See statement in Detailed Description.)
Information provided by:
Pfizer Identifier:
First received: January 25, 2006
Last updated: October 9, 2008
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given